Type 2 Diabetes Mellitus Treatment and Beyond: A Glance in Our Armamentarium
- PMID: 36908672
- PMCID: PMC9998458
- DOI: 10.1016/j.jacbts.2022.10.005
Type 2 Diabetes Mellitus Treatment and Beyond: A Glance in Our Armamentarium
Abstract
Keywords: atherosclerosis; liraglutide; molecular imaging; ultrasound.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
References
-
- Cosentino F., Grant P.J., Aboyans V., et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255–323. - PubMed
-
- Khan M.S., Fonarow G.C., McGuire D.K., et al. Glucagon-like peptide 1 receptor agonists and heart failure the need for further evidence generation and practice guidelines optimization. Circulation. 2020;142:1205–1218. - PubMed
-
- Nikolaou P.E., Mylonas N., Makridakis M., et al. Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect? Basic Res Cardiol. 2022;117:27. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
